Lilly Korea to expand presence in lung cancer market

Published: 2007-05-01 06:56:00
Updated: 2007-05-01 06:56:00
Lilly Korea plans to expand its presence in domestic lung cancer market as the national health insurance has covered ALIMTA (pemetrexed) from this April, following GEMZAR (gemcitabine).

Consistent evidence across the largest body of phase III trials demonstrates that GEMZAR is a leader in the ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.